Why is Neuland Laboratories Ltd ?
- PAT(Latest six months) At Rs 199.30 cr has Grown at 79.95%
- NET SALES(Latest six months) At Rs 1,091.24 cr has Grown at 35.22%
- ROCE(HY) Highest at 26.86%
- The technical trend has improved from Sideways on 04-Nov-26 and has generated 5.2% returns since then
- The stocks MACD and Bollinger Band technical factors are also Bullish
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 23.43%, its profits have risen by 131.1% ; the PEG ratio of the company is 0.4
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 0.59% over the previous quarter.
How much should you hold?
- Overall Portfolio exposure to Neuland Labs. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Neuland Labs. for you?
High Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
At Rs 199.30 cr has Grown at 79.95%
At Rs 1,091.24 cr has Grown at 35.22%
Highest at 26.86%
Highest at Rs 450.44 cr
Highest at 7.84 times
At Rs 449.66 cr has Fallen at -24.2% (vs previous 4Q average
At Rs 61.48 cr has Fallen at -61.5% (vs previous 4Q average
At Rs 51.63 cr has Fallen at -58.5% (vs previous 4Q average
At Rs 21.49 cr has Grown at 28.38%
Highest at 0.17 times
Here's what is working for Neuland Labs.
Cash and Cash Equivalents
Debtors Turnover Ratio
Here's what is not working for Neuland Labs.
Net Sales (Rs Cr)
PBT less Other Income (Rs Cr)
PAT (Rs Cr)
Interest Paid (Rs cr)
Debt-Equity Ratio